Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan R Smyth

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
Journal of the Royal Society of Medicine|June 25, 2010
Minimizing the toxicity of aminoglycosides in cystic fibrosisAlan R Smyth
Thorax|April 15, 2010
Pseudomonas eradication in cystic fibrosis: who will join the ELITE?Alan R Smyth
Paediatric Respiratory Reviews|December 24, 2013
Evidence into practice: how do we get past the roadblocks?Alan R Smyth
The Lancet. Child & Adolescent Health|January 30, 2026
Paracetamol, pyrexia, and the prevention of atopy: lessons from PIPPA TamarikiAlan R Smyth
American Journal of Respiratory and Critical Care Medicine|February 3, 2012
Birth cohorts in childhood asthma: lessons and limitationsAlan R Smyth
The Cochrane Database of Systematic Reviews|February 6, 2014
Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosisAlan R Smyth, Jayesh Bhatt
The Cochrane Database of Systematic Reviews|January 22, 2010
Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosisAlan R Smyth, Jayesh Bhatt
The Cochrane Database of Systematic Reviews|February 17, 2012
Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosisAlan R Smyth, Jayesh Bhatt
The Cochrane Database of Systematic Reviews|November 25, 2014
Prophylactic anti-staphylococcal antibiotics for cystic fibrosisAlan R Smyth, Sarah Walters
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 1, 2026
Maldigestion, dysbiosis, inflammation and dysmotility: a toxic tetrad in the CF gutRosara Bass, Alan R Smyth
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
Journal of the Royal Society of Medicine|June 25, 2010
Minimizing the toxicity of aminoglycosides in cystic fibrosisAlan R Smyth
Thorax|April 15, 2010
Pseudomonas eradication in cystic fibrosis: who will join the ELITE?Alan R Smyth
Paediatric Respiratory Reviews|December 24, 2013
Evidence into practice: how do we get past the roadblocks?Alan R Smyth
The Lancet. Child & Adolescent Health|January 30, 2026
Paracetamol, pyrexia, and the prevention of atopy: lessons from PIPPA TamarikiAlan R Smyth
American Journal of Respiratory and Critical Care Medicine|February 3, 2012
Birth cohorts in childhood asthma: lessons and limitationsAlan R Smyth
The Cochrane Database of Systematic Reviews|February 6, 2014
Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosisAlan R Smyth, Jayesh Bhatt
The Cochrane Database of Systematic Reviews|January 22, 2010
Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosisAlan R Smyth, Jayesh Bhatt
The Cochrane Database of Systematic Reviews|February 17, 2012
Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosisAlan R Smyth, Jayesh Bhatt
The Cochrane Database of Systematic Reviews|November 25, 2014
Prophylactic anti-staphylococcal antibiotics for cystic fibrosisAlan R Smyth, Sarah Walters
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 1, 2026
Maldigestion, dysbiosis, inflammation and dysmotility: a toxic tetrad in the CF gutRosara Bass, Alan R Smyth
Pageof 13